Publicacions
El coneixement generat a IrsiCaixa es comparteix amb la comunitat científica a través de la publicació d’articles a revistes científiques d’alt impacte.
![Imatge de Publicacions](/sites/default/files/styles/3_1_small/public/2022-11/Portada_publicacions-petita_0.jpg?h=c6980913&itok=oZMso2V6)
ADAR1 affects HCV infection by modulating innate immune response.
CD32 expression is associated to T-cell activation and is not a marker of the HIV-1 reservoir.
Antiviral treatment strategies based on gene silencing and genome editing.
Evaluation of the Innate Immune Modulator Acitretin as a Strategy To Clear the HIV Reservoir.
Chiral Indolylarylsulfone Non-Nucleoside Reverse Transcriptase Inhibitors as New Potent and Broad Spectrum Anti-HIV-1 Agents.
SAMHD1 is active in cycling cells permissive to HIV-1 infection.
RNA editing by ADAR1 regulates innate and antiviral immune functions in primary macrophages.
The G1/S Specific Cyclin D2 Is a Regulator of HIV-1 Restriction in Non-proliferating Cells.
Long-term HIV-1 infection induces an antiviral state in primary macrophages.
Inhibition of herpes simplex virus type 1 by the CDK6 inhibitor PD-0332991 (palbociclib) through the control of SAMHD1.